Science and Technology
When will the FDA reclassify BPC-157 to Category 1?
FDA - BPC
Markets
Before 2027
69%
Before November
59%
Before September
31%
Before July
11%
Rules
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
Outcome verified from Food and Drug Administration.
Additional prohibitions
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.
Legal
By trading on this market, you agree to the Trading prohibitions, Member agreement, and DFlow terms of service.